Clinical Trial Update: A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial update on a fixed-dose tablet containing two FDA-approved HIV drugs for treatment-naive patients; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: GlaxoSmithKline | Conditions: HIV Infection | Phase 3 | Status: COMPLETED